GEN Exclusives

More »
New Products

Related to Low Dead Volume Reservoir

    • Electronic Pipette
    • Integra Biosciences
    • Designed to enable labs to process samples simply, the VIAFLO 384 is a handheld 384-channel electronic pipette that allows the transfer of 384 samples simultaneously. The VIAFLO 384 offers good sample throughput as well as low sample and reagent us
    • Apoptosis-Measuring Reagent
    • Essen BioScience
    • The CellPlayer Caspase-3/7 apoptosis reagent is designed to fluoresce upon activation of Caspase-3/7 in living cells. This mix-and-read reagent can be multiplexed with measurements of proliferation to differentiate inhibition of proliferation from
    • Flow Cytometry Reagent Kits
    • Beckman Coulter
    • PerFix-Expose and PerFix-nc, reagent kits designed to reveal the cytoplasmic and nuclear compartments of the cell, were developed for use on Gallios and Navios series flow cytometers. With the PerFix-Expose (phospho-epitope exposure) kit, samples c
    • PCR Reagents
    • Thermo Fisher Scientific
    • Phusion Green High-Fidelity DNA Polymerase and Luminaris Color qPCR master mixes utilize tracking dyes that are meant to speed up the pipetting process. By providing a visual confirmation, the mixes are designed to reduce the chance of human error
    • Reagent Reservoirs
    • Integra Biosciences
    • Adopting a standard ANSI/SLAS footprint, an extended range of reagent reservoirs (100 mL and 300 mL) is available. The reservoirs are compatible with most liquid-handling systems including Viaflo 96 and Viaflo 384 handheld multichannel electronic p
  • Page 1 of 1 (5 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?